» Articles » PMID: 27790029

Retrospective Analysis of Treatment Modalities in Diabetic Muscle Infarction

Overview
Publisher Dove Medical Press
Specialty Rheumatology
Date 2014 Jan 10
PMID 27790029
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic muscle infarction (DMI) is a spontaneous necrosis of skeletal muscle of unknown etiology. The major risk factor is longstanding uncontrolled diabetes mellitus (DM). Optimal treatment for DMI is not known. The purpose of this study was to analyze the outcome of surgical treatment, physiotherapy, and bed rest in DMI.

Methods: We searched Medline from its inception to April 2013. We selected cases that provided sufficient data on recovery duration, recurrences, and non-recurrences. Baseline characteristics, including age, sex, microvascular complications, lesion size estimated on magnetic resonance imaging, type of diabetes, and duration of diabetes were assessed. The primary outcome was mean time to recovery from initial treatment and secondary outcomes were mean time to recurrence and recurrence rate.

Results: Mean time to recovery was 149 (95% confidence interval [CI] 113-186), 71 (95% CI 47-96), and 43 (95% CI 30-57) days for surgery, physiotherapy and bed rest, respectively. These figures were statistically significant only for surgery versus physiotherapy and surgery versus bed rest (<0.01). Mean time to recurrence was 30, 107, and 297 days for surgery, physiotherapy, and bed rest, respectively. The recurrence rate was 57%, 44%, and 24% for surgery, physiotherapy, and bed rest, respectively.

Conclusion: Our results show a similar outcome for physiotherapy as compared with bed rest. It also confirms nonsurgical treatment as a better therapeutic option compared with surgical treatment.

Citing Articles

Diabetic Muscle Infarction-A Rare Diabetic Complication: Literature Review and Case Report.

Rabczynski M, Fenc M, Kuznik E, Lubieniecki P, Halon A Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834084 PMC: 9966745. DOI: 10.3390/ijerph20043390.


Diabetic muscle infarction: often misdiagnosed and mismanaged.

Verjee M, Abdelsamad N, Qureshi S, Malik R Diabetes Metab Syndr Obes. 2019; 12:285-290.

PMID: 30881071 PMC: 6408199. DOI: 10.2147/DMSO.S185839.


Diabetic muscle infarction: a systematic review.

Horton W, Taylor J, Ragland T, Subauste A BMJ Open Diabetes Res Care. 2015; 3(1):e000082.

PMID: 25932331 PMC: 4410119. DOI: 10.1136/bmjdrc-2015-000082.

References
1.
Brower R . Consequences of bed rest. Crit Care Med. 2010; 37(10 Suppl):S422-8. DOI: 10.1097/CCM.0b013e3181b6e30a. View

2.
Bjornskov E, Carry M, KATZ F, Lefkowitz J, Ringel S . Diabetic muscle infarction: a new perspective on pathogenesis and management. Neuromuscul Disord. 1995; 5(1):39-45. DOI: 10.1016/0960-8966(94)e0027-6. View

3.
Schattner A, Zornitzki T, Adi M, Friedman J . Painful swelling in the thigh: diabetic muscle infarction. CMAJ. 2009; 180(1):72-4. PMC: 2612048. DOI: 10.1503/cmaj.080572. View

4.
Ali A, Conti M, Massucco P, Trovati M . Diabetic muscle infarction associated with multiple autoimmune disorders, IgA deficiency and a catastrophically poor glycaemic control: a case report. Diabetes Nutr Metab. 2003; 16(2):134-7. View

5.
BANKER B, Chester C . Infarction of thigh muscle in the diabetic patient. Neurology. 1973; 23(7):667-77. DOI: 10.1212/wnl.23.7.667. View